News

Filter

Current filters:

Acceleron Pharma

Acceleron collaborates with Celgene on ACE-011 program in $242 million deal

05-08-2011

Expanding on a previous partnership, privately-held US drug developer Acceleron Pharma has entered into…

Acceleron PharmaCelgeneLicensingOncologyPharmaceuticalResearch

Shire to pay nearly $500 million to expand rare diseases pipeline in deal with Acceleron Pharma

10-09-2010

Ireland-headquartered drugmaker Shire (LSE: SHP) plans to expand its human genetic therapies pipeline…

Acceleron PharmaLicensingPharmaceuticalRare diseasesShire

COMPANY SPOTLIGHT

Menarini

Back to top